Methods: In vivo test 28 days by WHO had been carried out in Gia Lai for evaluations the treatment efficacy of artesunate monotherapy for 7-day course (total doses 16 mg per kg) and in vivo test 42 days with Dihydroartemisinin - piperaquine phosphate (Arterakine) 3-day course regimen.